APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Zoster Vaccine Live

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Zoster Vaccine Live Market Analysis and Forecast 2026-2032

Report ID 174048960219 December 2025196 pages

Choose your research edition.

Industry ResearchZoster Vaccine Live Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Zoster Vaccine Live Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Zoster Vaccine Live Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zoster Vaccine Live Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Zoster Vaccine Live Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Zoster Vaccine Live market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Zoster Vaccine Live is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Zoster Vaccine Live is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Zoster Vaccine Live is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Zoster Vaccine Live is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Zoster Vaccine Live include Merck and GSK etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Zoster Vaccine Live, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Zoster Vaccine Live, also provides the sales of main regions and countries. Of the upcoming market potential for Zoster Vaccine Live, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Zoster Vaccine Live sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Zoster Vaccine Live market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Zoster Vaccine Live sales, projected growth trends, production technology, application and end-user industry.

Zoster Vaccine Live Segment by Company

Merck

GSK

Zoster Vaccine Live Segment by Type

Monovalent Vaccine

Combination Vaccine

Zoster Vaccine Live Segment by Application

Kids Injection

Adults Injection

Zoster Vaccine Live Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zoster Vaccine Live market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zoster Vaccine Live and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zoster Vaccine Live.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Zoster Vaccine Live in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Zoster Vaccine Live manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Zoster Vaccine Live sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Zoster Vaccine Live Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Monovalent Vaccine Major Manufacturers Table 3. Combination Vaccine Major Manufacturers Table 4. Global Zoster Vaccine Live Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Kids Injection Major Manufacturers Table 6. Adults Injection Major Manufacturers Table 7. Zoster Vaccine Live Industry Trends Table 8. Zoster Vaccine Live Industry Drivers Table 9. Zoster Vaccine Live Industry Opportunities and Challenges Table 10. Zoster Vaccine Live Industry Restraints Table 11. Global Zoster Vaccine Live Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Zoster Vaccine Live Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Zoster Vaccine Live Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Zoster Vaccine Live Revenue Market Share by Region (2021-2026) Table 15. Global Zoster Vaccine Live Revenue Market Share by Region (2027-2032) Table 16. Global Zoster Vaccine Live Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Zoster Vaccine Live Sales by Region (2021-2026) & (K Units) Table 18. Global Zoster Vaccine Live Sales by Region (2027-2032) & (K Units) Table 19. Global Zoster Vaccine Live Sales Market Share by Region (2021-2026) Table 20. Global Zoster Vaccine Live Sales Market Share by Region (2027-2032) Table 21. Global Zoster Vaccine Live Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Zoster Vaccine Live Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Zoster Vaccine Live Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Zoster Vaccine Live Sales Market Share by Manufacturers (2021-2026) Table 25. Global Zoster Vaccine Live Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Zoster Vaccine Live Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Zoster Vaccine Live Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Zoster Vaccine Live Manufacturers, Product Type & Application Table 29. Global Zoster Vaccine Live Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Zoster Vaccine Live by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Zoster Vaccine Live Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Zoster Vaccine Live Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Zoster Vaccine Live Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Zoster Vaccine Live Revenue Market Share by Type (2021-2026) Table 36. Global Zoster Vaccine Live Revenue Market Share by Type (2027-2032) Table 37. Global Zoster Vaccine Live Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Zoster Vaccine Live Sales by Type (2021-2026) & (K Units) Table 39. Global Zoster Vaccine Live Sales by Type (2027-2032) & (K Units) Table 40. Global Zoster Vaccine Live Sales Market Share by Type (2021-2026) Table 41. Global Zoster Vaccine Live Sales Market Share by Type (2027-2032) Table 42. Global Zoster Vaccine Live Price by Type (2021-2026) & (US$/Unit) Table 43. Global Zoster Vaccine Live Price by Type (2027-2032) & (US$/Unit) Table 44. Global Zoster Vaccine Live Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Zoster Vaccine Live Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Zoster Vaccine Live Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Zoster Vaccine Live Revenue Market Share by Application (2021-2026) Table 48. Global Zoster Vaccine Live Revenue Market Share by Application (2027-2032) Table 49. Global Zoster Vaccine Live Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Zoster Vaccine Live Sales by Application (2021-2026) & (K Units) Table 51. Global Zoster Vaccine Live Sales by Application (2027-2032) & (K Units) Table 52. Global Zoster Vaccine Live Sales Market Share by Application (2021-2026) Table 53. Global Zoster Vaccine Live Sales Market Share by Application (2027-2032) Table 54. Global Zoster Vaccine Live Price by Application (2021-2026) & (US$/Unit) Table 55. Global Zoster Vaccine Live Price by Application (2027-2032) & (US$/Unit) Table 56. Merck Company Information Table 57. Merck Business Overview Table 58. Merck Zoster Vaccine Live Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Merck Zoster Vaccine Live Product Portfolio Table 60. Merck Recent Development Table 61. GSK Company Information Table 62. GSK Business Overview Table 63. GSK Zoster Vaccine Live Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. GSK Zoster Vaccine Live Product Portfolio Table 65. GSK Recent Development Table 66. North America Zoster Vaccine Live Revenue by Type (2021-2026) & (US$ Million) Table 67. North America Zoster Vaccine Live Revenue by Type (2027-2032) & (US$ Million) Table 68. North America Zoster Vaccine Live Sales by Type (2021-2026) & (K Units) Table 69. North America Zoster Vaccine Live Sales by Type (2027-2032) & (K Units) Table 70. North America Zoster Vaccine Live Sales Price by Type (2021-2026) & (US$/Unit) Table 71. North America Zoster Vaccine Live Sales Price by Type (2027-2032) & (US$/Unit) Table 72. North America Zoster Vaccine Live Revenue by Application (2021-2026) & (US$ Million) Table 73. North America Zoster Vaccine Live Revenue by Application (2027-2032) & (US$ Million) Table 74. North America Zoster Vaccine Live Sales by Application (2021-2026) & (K Units) Table 75. North America Zoster Vaccine Live Sales by Application (2027-2032) & (K Units) Table 76. North America Zoster Vaccine Live Sales Price by Application (2021-2026) & (US$/Unit) Table 77. North America Zoster Vaccine Live Sales Price by Application (2027-2032) & (US$/Unit) Table 78. North America Zoster Vaccine Live Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. North America Zoster Vaccine Live Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 80. North America Zoster Vaccine Live Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 81. North America Zoster Vaccine Live Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 82. North America Zoster Vaccine Live Sales by Country (2021-2026) & (K Units) Table 83. North America Zoster Vaccine Live Sales by Country (2027-2032) & (K Units) Table 84. North America Zoster Vaccine Live Sales Price by Country (2021-2026) & (US$/Unit) Table 85. North America Zoster Vaccine Live Sales Price by Country (2027-2032) & (US$/Unit) Table 86. United States Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 87. Canada Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 88. Europe Zoster Vaccine Live Revenue by Type (2021-2026) & (US$ Million) Table 89. Europe Zoster Vaccine Live Revenue by Type (2027-2032) & (US$ Million) Table 90. Europe Zoster Vaccine Live Sales by Type (2021-2026) & (K Units) Table 91. Europe Zoster Vaccine Live Sales by Type (2027-2032) & (K Units) Table 92. Europe Zoster Vaccine Live Sales Price by Type (2021-2026) & (US$/Unit) Table 93. Europe Zoster Vaccine Live Sales Price by Type (2027-2032) & (US$/Unit) Table 94. Europe Zoster Vaccine Live Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Zoster Vaccine Live Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Zoster Vaccine Live Sales by Application (2021-2026) & (K Units) Table 97. Europe Zoster Vaccine Live Sales by Application (2027-2032) & (K Units) Table 98. Europe Zoster Vaccine Live Sales Price by Application (2021-2026) & (US$/Unit) Table 99. Europe Zoster Vaccine Live Sales Price by Application (2027-2032) & (US$/Unit) Table 100. Europe Zoster Vaccine Live Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Zoster Vaccine Live Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. Europe Zoster Vaccine Live Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. Europe Zoster Vaccine Live Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 104. Europe Zoster Vaccine Live Sales by Country (2021-2026) & (K Units) Table 105. Europe Zoster Vaccine Live Sales by Country (2027-2032) & (K Units) Table 106. Europe Zoster Vaccine Live Sales Price by Country (2021-2026) & (US$/Unit) Table 107. Europe Zoster Vaccine Live Sales Price by Country (2027-2032) & (US$/Unit) Table 108. Germany Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 109. France Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 110. U.K. Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 111. Italy Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 112. Netherlands Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 113. China Zoster Vaccine Live Revenue by Type (2021-2026) & (US$ Million) Table 114. China Zoster Vaccine Live Revenue by Type (2027-2032) & (US$ Million) Table 115. China Zoster Vaccine Live Sales by Type (2021-2026) & (K Units) Table 116. China Zoster Vaccine Live Sales by Type (2027-2032) & (K Units) Table 117. China Zoster Vaccine Live Sales Price by Type (2021-2026) & (US$/Unit) Table 118. China Zoster Vaccine Live Sales Price by Type (2027-2032) & (US$/Unit) Table 119. China Zoster Vaccine Live Revenue by Application (2021-2026) & (US$ Million) Table 120. China Zoster Vaccine Live Revenue by Application (2027-2032) & (US$ Million) Table 121. China Zoster Vaccine Live Sales by Application (2021-2026) & (K Units) Table 122. China Zoster Vaccine Live Sales by Application (2027-2032) & (K Units) Table 123. China Zoster Vaccine Live Sales Price by Application (2021-2026) & (US$/Unit) Table 124. China Zoster Vaccine Live Sales Price by Application (2027-2032) & (US$/Unit) Table 125. Asia Zoster Vaccine Live Revenue by Type (2021-2026) & (US$ Million) Table 126. Asia Zoster Vaccine Live Revenue by Type (2027-2032) & (US$ Million) Table 127. Asia Zoster Vaccine Live Sales by Type (2021-2026) & (K Units) Table 128. Asia Zoster Vaccine Live Sales by Type (2027-2032) & (K Units) Table 129. Asia Zoster Vaccine Live Sales Price by Type (2021-2026) & (US$/Unit) Table 130. Asia Zoster Vaccine Live Sales Price by Type (2027-2032) & (US$/Unit) Table 131. Asia Zoster Vaccine Live Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Zoster Vaccine Live Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Zoster Vaccine Live Sales by Application (2021-2026) & (K Units) Table 134. Asia Zoster Vaccine Live Sales by Application (2027-2032) & (K Units) Table 135. Asia Zoster Vaccine Live Sales Price by Application (2021-2026) & (US$/Unit) Table 136. Asia Zoster Vaccine Live Sales Price by Application (2027-2032) & (US$/Unit) Table 137. Asia Zoster Vaccine Live Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia Zoster Vaccine Live Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. Asia Zoster Vaccine Live Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. Asia Zoster Vaccine Live Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 141. Asia Zoster Vaccine Live Sales by Country (2021-2026) & (K Units) Table 142. Asia Zoster Vaccine Live Sales by Country (2027-2032) & (K Units) Table 143. Asia Zoster Vaccine Live Sales Price by Country (2021-2026) & (US$/Unit) Table 144. Asia Zoster Vaccine Live Sales Price by Country (2027-2032) & (US$/Unit) Table 145. Japan Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 146. South Korea Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 147. India Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 148. Australia Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 149. China Taiwan Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 150. Southeast Asia Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 151. SAMEA Zoster Vaccine Live Revenue by Type (2021-2026) & (US$ Million) Table 152. SAMEA Zoster Vaccine Live Revenue by Type (2027-2032) & (US$ Million) Table 153. SAMEA Zoster Vaccine Live Sales by Type (2021-2026) & (K Units) Table 154. SAMEA Zoster Vaccine Live Sales by Type (2027-2032) & (K Units) Table 155. SAMEA Zoster Vaccine Live Sales Price by Type (2021-2026) & (US$/Unit) Table 156. SAMEA Zoster Vaccine Live Sales Price by Type (2027-2032) & (US$/Unit) Table 157. SAMEA Zoster Vaccine Live Revenue by Application (2021-2026) & (US$ Million) Table 158. SAMEA Zoster Vaccine Live Revenue by Application (2027-2032) & (US$ Million) Table 159. SAMEA Zoster Vaccine Live Sales by Application (2021-2026) & (K Units) Table 160. SAMEA Zoster Vaccine Live Sales by Application (2027-2032) & (K Units) Table 161. SAMEA Zoster Vaccine Live Sales Price by Application (2021-2026) & (US$/Unit) Table 162. SAMEA Zoster Vaccine Live Sales Price by Application (2027-2032) & (US$/Unit) Table 163. SAMEA Zoster Vaccine Live Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. SAMEA Zoster Vaccine Live Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. SAMEA Zoster Vaccine Live Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. SAMEA Zoster Vaccine Live Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 167. SAMEA Zoster Vaccine Live Sales by Country (2021-2026) & (K Units) Table 168. SAMEA Zoster Vaccine Live Sales by Country (2027-2032) & (K Units) Table 169. SAMEA Zoster Vaccine Live Sales Price by Country (2021-2026) & (US$/Unit) Table 170. SAMEA Zoster Vaccine Live Sales Price by Country (2027-2032) & (US$/Unit) Table 171. Brazil Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 172. Argentina Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 173. Chile Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 174. Colombia Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 175. Peru Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 176. Saudi Arabia Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 177. Israel Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 178. UAE Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 179. Turkey Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 180. Iran Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 181. Egypt Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Zoster Vaccine Live Distributors List Table 185. Zoster Vaccine Live Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Zoster Vaccine Live Image Figure 2. Global Zoster Vaccine Live Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zoster Vaccine Live Market Size Share 2021 VS 2025 VS 2032 Figure 4. Monovalent Vaccine Image Figure 5. Combination Vaccine Image Figure 6. Global Zoster Vaccine Live Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Zoster Vaccine Live Market Size Share 2021 VS 2025 VS 2032 Figure 8. Kids Injection Image Figure 9. Adults Injection Image Figure 10. Global Zoster Vaccine Live Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Figure 12. Global Zoster Vaccine Live Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Zoster Vaccine Live Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Zoster Vaccine Live Revenue Market Share by Region (2021-2032) Figure 15. Global Zoster Vaccine Live Sales (2021-2032) & (K Units) Figure 16. Global Zoster Vaccine Live Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Zoster Vaccine Live Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Zoster Vaccine Live Sales YoY (2021-2032) & (K Units) Figure 19. Europe Zoster Vaccine Live Sales YoY (2021-2032) & (K Units) Figure 20. China Zoster Vaccine Live Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Zoster Vaccine Live Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Zoster Vaccine Live Sales YoY (2021-2032) & (K Units) Figure 23. Global Zoster Vaccine Live Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Zoster Vaccine Live Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Zoster Vaccine Live Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Zoster Vaccine Live Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Zoster Vaccine Live Revenue Market Share by Type (2021-2032) Figure 29. Global Zoster Vaccine Live Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Zoster Vaccine Live Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Zoster Vaccine Live Sales Market Share by Type (2021-2032) Figure 32. Global Zoster Vaccine Live Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Zoster Vaccine Live Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Zoster Vaccine Live Revenue Market Share by Application (2021-2032) Figure 35. Global Zoster Vaccine Live Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Zoster Vaccine Live Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Zoster Vaccine Live Sales Market Share by Application (2021-2032) Figure 38. North America Zoster Vaccine Live Revenue Share by Type (2021-2032) Figure 39. North America Zoster Vaccine Live Sales Share by Type (2021-2032) Figure 40. North America Zoster Vaccine Live Revenue Share by Application (2021-2032) Figure 41. North America Zoster Vaccine Live Sales Share by Application (2021-2032) Figure 42. North America Zoster Vaccine Live Revenue Share by Country (2021-2032) Figure 43. North America Zoster Vaccine Live Sales Share by Country (2021-2032) Figure 44. Europe Zoster Vaccine Live Revenue Share by Type (2021-2032) Figure 45. Europe Zoster Vaccine Live Sales Share by Type (2021-2032) Figure 46. Europe Zoster Vaccine Live Revenue Share by Application (2021-2032) Figure 47. Europe Zoster Vaccine Live Sales Share by Application (2021-2032) Figure 48. Europe Zoster Vaccine Live Revenue Share by Country (2021-2032) Figure 49. Europe Zoster Vaccine Live Sales Share by Country (2021-2032) Figure 50. China Zoster Vaccine Live Revenue Share by Type (2021-2032) Figure 51. China Zoster Vaccine Live Sales Share by Type (2021-2032) Figure 52. China Zoster Vaccine Live Revenue Share by Application (2021-2032) Figure 53. China Zoster Vaccine Live Sales Share by Application (2021-2032) Figure 54. Asia Zoster Vaccine Live Revenue Share by Type (2021-2032) Figure 55. Asia Zoster Vaccine Live Sales Share by Type (2021-2032) Figure 56. Asia Zoster Vaccine Live Revenue Share by Application (2021-2032) Figure 57. Asia Zoster Vaccine Live Sales Share by Application (2021-2032) Figure 58. Asia Zoster Vaccine Live Revenue Share by Country (2021-2032) Figure 59. Asia Zoster Vaccine Live Sales Share by Country (2021-2032) Figure 60. SAMEA Zoster Vaccine Live Revenue Share by Type (2021-2032) Figure 61. SAMEA Zoster Vaccine Live Sales Share by Type (2021-2032) Figure 62. SAMEA Zoster Vaccine Live Revenue Share by Application (2021-2032) Figure 63. SAMEA Zoster Vaccine Live Sales Share by Application (2021-2032) Figure 64. SAMEA Zoster Vaccine Live Revenue Share by Country (2021-2032) Figure 65. SAMEA Zoster Vaccine Live Sales Share by Country (2021-2032) Figure 66. Zoster Vaccine Live Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Zoster Vaccine Live Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccine
  • Combination Vaccine
Applications
  • Kids Injection
  • Adults Injection
Companies covered
  • Merck
  • GSK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Zoster Vaccine Live Market by Type
  3. 1.2.1 Global Zoster Vaccine Live Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Monovalent Vaccine
  5. 1.2.3 Combination Vaccine
  6. 1.3 Zoster Vaccine Live Market by Application
  7. 1.3.1 Global Zoster Vaccine Live Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Kids Injection
  9. 1.3.3 Adults Injection
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Zoster Vaccine Live Market Dynamics
  1. 2.1 Zoster Vaccine Live Industry Trends
  2. 2.2 Zoster Vaccine Live Industry Drivers
  3. 2.3 Zoster Vaccine Live Industry Opportunities and Challenges
  4. 2.4 Zoster Vaccine Live Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Zoster Vaccine Live Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Zoster Vaccine Live Revenue by Region
  3. 3.2.1 Global Zoster Vaccine Live Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Zoster Vaccine Live Revenue by Region (2021-2026)
  5. 3.2.3 Global Zoster Vaccine Live Revenue by Region (2027-2032)
  6. 3.2.4 Global Zoster Vaccine Live Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Zoster Vaccine Live Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Zoster Vaccine Live Sales by Region
  9. 3.4.1 Global Zoster Vaccine Live Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Zoster Vaccine Live Sales by Region (2021-2026)
  11. 3.4.3 Global Zoster Vaccine Live Sales by Region (2027-2032)
  12. 3.4.4 Global Zoster Vaccine Live Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Zoster Vaccine Live Revenue by Manufacturers
  2. 4.1.1 Global Zoster Vaccine Live Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Zoster Vaccine Live Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Zoster Vaccine Live Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Zoster Vaccine Live Sales by Manufacturers
  6. 4.2.1 Global Zoster Vaccine Live Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Zoster Vaccine Live Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Zoster Vaccine Live Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Zoster Vaccine Live Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Zoster Vaccine Live Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Zoster Vaccine Live Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Zoster Vaccine Live Manufacturers, Product Type & Application
  13. 4.7 Global Zoster Vaccine Live Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Zoster Vaccine Live Market CR5 and HHI
  16. 4.8.2 2025 Zoster Vaccine Live Tier 1, Tier 2, and Tier 3
5 Zoster Vaccine Live Market by Type
  1. 5.1 Global Zoster Vaccine Live Revenue by Type
  2. 5.1.1 Global Zoster Vaccine Live Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Zoster Vaccine Live Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Zoster Vaccine Live Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Zoster Vaccine Live Sales by Type
  6. 5.2.1 Global Zoster Vaccine Live Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Zoster Vaccine Live Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Zoster Vaccine Live Sales Market Share by Type (2021-2032)
  9. 5.3 Global Zoster Vaccine Live Price by Type
6 Zoster Vaccine Live Market by Application
  1. 6.1 Global Zoster Vaccine Live Revenue by Application
  2. 6.1.1 Global Zoster Vaccine Live Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Zoster Vaccine Live Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Zoster Vaccine Live Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Zoster Vaccine Live Sales by Application
  6. 6.2.1 Global Zoster Vaccine Live Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Zoster Vaccine Live Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Zoster Vaccine Live Sales Market Share by Application (2021-2032)
  9. 6.3 Global Zoster Vaccine Live Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Zoster Vaccine Live Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Zoster Vaccine Live Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 GSK
  8. 7.2.1 GSK Company Information
  9. 7.2.2 GSK Business Overview
  10. 7.2.3 GSK Zoster Vaccine Live Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GSK Zoster Vaccine Live Product Portfolio
  12. 7.2.5 GSK Recent Developments
8 North America
  1. 8.1 North America Zoster Vaccine Live Market Size by Type
  2. 8.1.1 North America Zoster Vaccine Live Revenue by Type (2021-2032)
  3. 8.1.2 North America Zoster Vaccine Live Sales by Type (2021-2032)
  4. 8.1.3 North America Zoster Vaccine Live Price by Type (2021-2032)
  5. 8.2 North America Zoster Vaccine Live Market Size by Application
  6. 8.2.1 North America Zoster Vaccine Live Revenue by Application (2021-2032)
  7. 8.2.2 North America Zoster Vaccine Live Sales by Application (2021-2032)
  8. 8.2.3 North America Zoster Vaccine Live Price by Application (2021-2032)
  9. 8.3 North America Zoster Vaccine Live Market Size by Country
  10. 8.3.1 North America Zoster Vaccine Live Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Zoster Vaccine Live Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Zoster Vaccine Live Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Zoster Vaccine Live Market Size by Type
  2. 9.1.1 Europe Zoster Vaccine Live Revenue by Type (2021-2032)
  3. 9.1.2 Europe Zoster Vaccine Live Sales by Type (2021-2032)
  4. 9.1.3 Europe Zoster Vaccine Live Price by Type (2021-2032)
  5. 9.2 Europe Zoster Vaccine Live Market Size by Application
  6. 9.2.1 Europe Zoster Vaccine Live Revenue by Application (2021-2032)
  7. 9.2.2 Europe Zoster Vaccine Live Sales by Application (2021-2032)
  8. 9.2.3 Europe Zoster Vaccine Live Price by Application (2021-2032)
  9. 9.3 Europe Zoster Vaccine Live Market Size by Country
  10. 9.3.1 Europe Zoster Vaccine Live Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Zoster Vaccine Live Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Zoster Vaccine Live Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Zoster Vaccine Live Market Size by Type
  2. 10.1.1 China Zoster Vaccine Live Revenue by Type (2021-2032)
  3. 10.1.2 China Zoster Vaccine Live Sales by Type (2021-2032)
  4. 10.1.3 China Zoster Vaccine Live Price by Type (2021-2032)
  5. 10.2 China Zoster Vaccine Live Market Size by Application
  6. 10.2.1 China Zoster Vaccine Live Revenue by Application (2021-2032)
  7. 10.2.2 China Zoster Vaccine Live Sales by Application (2021-2032)
  8. 10.2.3 China Zoster Vaccine Live Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Zoster Vaccine Live Market Size by Type
  2. 11.1.1 Asia Zoster Vaccine Live Revenue by Type (2021-2032)
  3. 11.1.2 Asia Zoster Vaccine Live Sales by Type (2021-2032)
  4. 11.1.3 Asia Zoster Vaccine Live Price by Type (2021-2032)
  5. 11.2 Asia Zoster Vaccine Live Market Size by Application
  6. 11.2.1 Asia Zoster Vaccine Live Revenue by Application (2021-2032)
  7. 11.2.2 Asia Zoster Vaccine Live Sales by Application (2021-2032)
  8. 11.2.3 Asia Zoster Vaccine Live Price by Application (2021-2032)
  9. 11.3 Asia Zoster Vaccine Live Market Size by Country
  10. 11.3.1 Asia Zoster Vaccine Live Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Zoster Vaccine Live Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Zoster Vaccine Live Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Zoster Vaccine Live Market Size by Type
  2. 12.1.1 SAMEA Zoster Vaccine Live Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Zoster Vaccine Live Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Zoster Vaccine Live Price by Type (2021-2032)
  5. 12.2 SAMEA Zoster Vaccine Live Market Size by Application
  6. 12.2.1 SAMEA Zoster Vaccine Live Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Zoster Vaccine Live Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Zoster Vaccine Live Price by Application (2021-2032)
  9. 12.3 SAMEA Zoster Vaccine Live Market Size by Country
  10. 12.3.1 SAMEA Zoster Vaccine Live Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Zoster Vaccine Live Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Zoster Vaccine Live Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Zoster Vaccine Live Value Chain Analysis
  2. 13.1.1 Zoster Vaccine Live Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Zoster Vaccine Live Production Mode & Process
  6. 13.2 Zoster Vaccine Live Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Zoster Vaccine Live Distributors
  9. 13.2.3 Zoster Vaccine Live Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst